Meprindon en es it fr

Meprindon Brand names, Meprindon Analogs

Meprindon Brand Names Mixture

  • No information avaliable

Meprindon Chemical_Formula


Meprindon RX_link

No information avaliable

Meprindon fda sheet

Meprindon msds (material safety sheet)

Meprindon Synthesis Reference

No information avaliable

Meprindon Molecular Weight

309.469 g/mol

Meprindon Melting Point

< 25 oC

Meprindon H2O Solubility

Soluble as HCl salt

Meprindon State


Meprindon LogP


Meprindon Dosage Forms

Tablets (oral, 1 mg)

Meprindon Indication

Used for the symptomatic treatment of parkinsonism.

Meprindon Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprindon Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprindon side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprindon Patient Information

Meprindon Organisms Affected

Humans and other mammals